Announced Fri, 24 Jul · 21:28 IST
Annual Report for Financial Year 2025-26 filed with BSE
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Astonea Labs Limited submitted its Annual Report for FY ended 31 March 2026. Revenue grew 51 percent to 147.58 Crore from 97.51 Crore. Profit after tax moderated to 4.52 Crore from 5.35 Crore. Net worth jumped to 57.13 Crore from 18.41 Crore after listing on BSE SME in June 2025. Company set up US subsidiary Astonea LLC and acquired stake in Damaira Pharmaceuticals.
Likely market impact
First post-listing annual report shows revenue up 51 percent to 147.58 Cr, profit moderated, plus US subsidiary and pharma acquisition.